Summary
The metabolic fate of a new diuretic, tienilic acid, was investigated in Wistar rats, Swiss mice, Beagle dogs, and large white pigs using the14C-labelled compound. Tienilic add and its metabolites were determined in bile, urine, and plasma following intravenous and oral administration. In general, only a small amount of unmetabolized drug is excreted. Biotransformation consists of two major metabolic routes; one is reduction and the other is oxidative hydrolysis of the molecule at the level of the carbonyl group. These two routes co-exist in all species studied, but the reduction route is prominent in the dog. Mass spectrometry was used to elucidate the structure of two metabolites and confirm it for the third.
Similar content being viewed by others
References
Dormard, Y., Levron, J.C., Adnot, P. and Lebedeff, T. (1976): Pharmacokinetic Study of 2,3-dichloro-4-[2-thienyl keto14C]phenoxyacetic acid (Tienilic acid) in animals. I. Localisation, distribution and elimination of14C-Tienillc acid in animals. Eur. J. Drug Metabol. Pharmacol, 1, 41–49.
Levron, J.C. (1976): Biotransformations d’un dérivé héterocyclique de l’acide phenoxyacetique: L’acide Tienilique14C. Etude comparée entre le rat, la souris, le pore, la brebis et le chien. Diplôme de l’Ecole Pratique des Hautes Etudes. Sorbonne, Paris.
Maurer, G., Roche, M., Darmenton, P. and Pacheco, H. (1976): Biological half-life and metabolism of a new diuretic dichloro 2,3-(thienyl-2-keto)-4 phenoxyacetic acid in the dog. Eur. J. Drug Metabol. pharmacok.,4, 202–205.
Levey, S. and Lewis, H.B. (1947): The Metabolism of Phenoxyacetic acid its homologues and some monochlorophenoxyacetic acids, new examples of oxidation, J. Biol, chem.,168, 213–221.
Klaassen, C.D. and Fitzgerald, T.J. (1974): Metabolism and biliary excretion of ethacrynic acid, J. Pharmacol. Exp. Ther.,191, 547–556.
Beyer, K.H., Baer, J.E., Michaelson, J.K. and Russo, H.F. (1965): Renotropic characteristics of ethacrynic acid: a phenoxyacetic saluretic diuretic agent, J. Pharmacol. Exp. Ther.,147, 1–22.
James, M.O. and Bend, J.R. (1976): Taurine conjugation of 2,4-Dichlorophenoxyacetic acid and phenylacetic acid in two marine species, Xenobiotica,16, 393–398.
Alexrod, J. (1956): The enzymatic cleavage of aromatic ethers, Biochem. J.,63, 634–639.
Gilette, J.R. and Kamm, J.J. (1960): The enzymatic formation of sulfoxides: The oxidation of chloropromazine and 4,4-Diaminodiphenylsulfide by guinea pig liver microsomes, J. Pharmacol. Exp. Ther.,130, 262–267.
Williams, R.T. (1961): The metabolism and toxicity of Arylthioureas Biochem. J.,80 1p-2p.
Meuldermans, W.E.G., Hurkmans, R.M.A., Lauwers, W.F.J., and Heykants, J.J.P. (1976): The in vitro metabolism of mebendazole by pig, rat and dog liver fractions. Eur. J. Drug Metabol. Pharmacok.,1, 35–40.
Lan, S.J., El Hawey, A.M., Dean, A.V. and Schreibe, E.C. (1975): Metabolism of p-(cyclopropylearbonyl) phenylacetic acid 1(SQ20-650) Species differences, Drug Metabolism and disposition,3, 171–179.
Brodie, R.R., Chasseaud, L.F., Elsom, F.F., Franklin, E.R. and Taylor, T. (1976): Antilipidemic drugs — Part 4: The metabolic fate of the hypolipidemic agent isopropyl-/4’-(p-chlorobenzoyl)-2-phenoxy-2-methyl/-propionate (LF 178) in rats, dogs and man, Arzneim.Forsch.,26, 896–901.
Dost, F.H. (1968): Grundlegen der pharmakokinetik, Georg Thieme Verlag, Stuttgart.
Author information
Authors and Affiliations
Additional information
mis
Tienilic acid = generic name, marketed under the name of DIFLUREX (French Trademark) by the ANPHAR Laboratory, 91380 Chilly-Mazarin (France).
Rights and permissions
About this article
Cite this article
Levron, J.C., Le Fur, J.M., Adnot, P. et al. Pharmacokinetic study of 2,3-dichloro 4- (2-thienyl keto14C) phenoxyacetic acid (tienilic acid) in animals. European Journal of Drug Metabolism and Pharmacokinetics 2, 107–120 (1977). https://doi.org/10.1007/BF03189295
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189295